Eli Lilly CDR (LLY0)
FSX
Closed
Aug 21, 2026
Day's Range
26.4052 wk Range
15.00Overview - LLY0 - Eli Lilly CDR
Key Statistics
Valuation
Enterprise Value
666.98B
P/E (Trailing)
‪37.71‬
PEG Ratio
‪1.44‬
Price / Sales (TTM)
‪10.82‬
Price / Book
‪24.33‬
EV / EBITDA
‪18.71‬
Profitability
Gross Margin
‪85.77%‬
Profit Margin
‪33.52%‬
Operating Margin
‪54.22%‬
Return on Assets
‪20.35%‬
Return on Equity
‪102.28%‬
Ownership
Shares Outstanding
891.50M
Float
26.93B
Price stats
Beta
‪0.50‬
50-Day Avg
‪25.60‬
200-Day Avg
‪23.18‬
Dividends
Payout Ratio
‪20.82%‬
Frequency
Quarterly
Market Cap - LLY0 - Eli Lilly CDR
Peers - LLY0 - Eli Lilly CDR
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on FSX.
- LLY0FSXEli Lilly CDR862.66BMarket Cap+42.05%52-week change37.71P/E (Trailing)‪33.52%‬Profit Margin
- LLYFSXEli Lilly and Company967.12BMarket Cap+44.79%52-week change42.45P/E (Trailing)‪33.52%‬Profit Margin
- JNJFSXJohnson & Johnson559.57BMarket Cap+34.23%52-week change31.59P/E (Trailing)‪21.48%‬Profit Margin
- JNJ0FSXJohnson & Johnson CDR515.60BMarket Cap+32.69%52-week change28.49P/E (Trailing)‪21.48%‬Profit Margin
- 4AB0FSXAbbVie Inc. CDR404.07BMarket Cap+27.27%52-week change75.63P/E (Trailing)‪9.80%‬Profit Margin
- 4ABFSXAbbVie Inc.400.95BMarket Cap+21.11%52-week change74.64P/E (Trailing)‪9.80%‬Profit Margin
- RHOFSXRoche Holding AG323.48BMarket Cap+28.47%52-week change24.76P/E (Trailing)‪19.60%‬Profit Margin
Profile Summary - LLY0 - Eli Lilly CDR
About
Eli Lilly CDR is a Canadian Depositary Receipt (CAD Hedged) providing Canadian investors exposure to Eli Lilly and Company, a leading global pharmaceutical firm founded in 1876 and headquartered in Indianapolis, Indiana. Eli Lilly engages in the discovery, development, manufacture, and sale of innovative prescription…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
